Veskon
Back to feed
Lead dossierLanded18:43

CT-2026-301 Site Readiness | Clinical Trial Operations

mn1studio.online · Discovered 1 hr. ago

Warm leadSaaS
Visit site

Summary

Executive dashboard for Phase III trial CT-2026-301: site risk, activation readiness, regulatory status and enrollment across 24 US sites.

Audience
General
Category
SaaS
Country
Unknown
Status
Live

Technology stack

Tailwind CSSCloudflareHosting: Cloudflare